Increasing Prevalence Of Constipation To Boost The Lactulose Market Growth

Lactulose Market
Lactulose Market

Lactulose Market By Type (Crystalline Lactulose, Liquid Lactulose By End User (Pharmaceuticals, Food Ingredient and Other) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030

The global Lactulose Market is estimated to be valued at US$ 169.2 million in 2021 and is expected to exhibit a CAGR of 3.6 % over the forecast period, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Lactulose is a kind of laxative known as an osmotic laxative. It is broken down in the bowel into particles that abstract liquid out from the body and into the bowel to smoothen poo and make it convenient to flow. People with hepatic disorders can often lead to some problems related to brain.

Competitive Landscape:

Key players involved in the growth of global lactulose for market are Abbott Morinage, Biofac, Inalco, FreseniusKabi, DandongKangfu, Relax and Milei

Market Key Drivers:

Increasing prevalence of constipation is expected to augment the growth of global Lactulose Market. For instance, as per NCBI around 16% of the global population suffer from constipation annually.

Rising elderly population and increasing gastrointestinal diseases is projected to propel the growth of global lactulose market. For instance, as per WHO, around 40% of the global population suffer from gastrointestinal disorder.

The Food Stabilizer Market in Europe and North America is anticipated to grow as a result of increased rates of foodborne illnesses and growing knowledge of the benefits of food stabilisers' antibacterial properties.

Covid-19 Impact Analysis:

The Covid-19 outbreak has adversely affected the growth of global lactulose for market due to the imposition of strict lockdown. The surge in cases has led to the delay in the treatment of others disease. The pandemic has led to the disruption in expansion of healthcare infrastructure and interrupted the supply chain. The halt in manufacturing and production units also impeded the market growth.

Key Takeaways:

The global Lactulose Market is anticipated to exhibit a CAGR of 3.6 % during the forecast period owing to the rising cases of hepatic encephalopathy. For instance, as per NIH, around 35 to 40% of the global population suffer from encephalopathy.

Among regions, North America, Europe and Asia Pacific are expected to witness robust growth in global lactulose Market due to rising gastrointestinal diseases, hepatic encephalopathy and constipation. For instance, as per NIH, over 4 million people in U.S suffer from frequent constipation.

Comments

Post a Comment

Popular posts from this blog

Sarcopenia Treatment; Training and Physical Exercise Is Key to Counteract Sarcopenia

Image
Sarcopenia Treatment A primary Sarcopenia Treatment is exercise. Researchers have identified resistance training as the specific form of exercise that is most beneficial to individuals with sarcopenia. At present, resistance exercise, protein supplementation, and vitamin D have been established as the basic treatment of sarcopenia. Recent clinical trials on sarcopenia therapies such as physical exercise, nutraceutical, and pharmaceutical interventions have revealed that exercise is the only effective strategy shown to alleviate sarcopenia. Sarcopenia refers to a loss of muscle mass specifically related to aging. It's normal to lose some muscle mass as people age. Sarcopenia has been defined as an age-related, involuntary loss of skeletal muscle mass and strength. Although aging is the main cause of sarcopenia, some other factors contribute to the loss of muscle mass. Getting little or no physical activity on a regular basis puts people at an increased risk of developing sarcopenia
Read more

Bioresorbable Implants Can Also Help To Prevent Complications And Speed Up The Recovery Process

Image
Bioresorbable Implants Medical implants, either passive for structural support or for diagnosis and therapy with active electronics, are widely used in surgical applications. Although they have shown long-term biocompatibility, their removal imposes physical, biological and economical burdens on patients. To overcome this drawback, implantable devices exhibiting biodegradation in the body have been developed. These implants disappear inside the body after a certain time of use, and can be replaced with natural bone. The resorption of Bioresorbable Implants is driven by hydrolysis of the bonds linking their monomers. The amorphous portions of the polymer degrade first, while the crystalline regions remain intact and provide most of their mechanical strength. The monomers are then broken down into lactic and glycolic acids, which are converted to pyruvate and then processed through the citric acid cycle into water and carbon dioxide. The Bioresorbable Implants Market was valued at US$
Read more

Increasing Developments by Key Players Are Expected To Augment the Growth of the Global Digital Pathology Market

Image
 Digital Pathology Digital Pathology Market , by Product Type (Image Analysis Software, Scanner {Bright Field Scanner, Fluorescence Scanner}, Services {Installation & Integration, Maintenance Services, Consulting Services}), by Therapeutic Area (Oncology, Hematology, Autoimmune Disorder, Dermatology, and Others), by Technology (Immunohistochemistry, ISH & FISH, Immunofluorescence and others) End User (Pharmaceutical & Biotechnology Companies, Diagnostic Labs, Hospital Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030. The global Digital Pathology Market is anticipated to reach an estimated value of US$ 884.4 million in 2023 and is projected to grow at a CAGR of 12.2% from 2023 to 2030. Market Overview: Digital pathology refers to the practice of digitizing glass slides containing tissue samples and analyzing them using digital imaging technology
Read more